<
IQVIA Holdings, US46266C1053

IQVIA Holdings stock lacks a fresh catalyst but stays data rich

Published on 09/02/2026 at 16:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IQVIA Holdings stock remains closely watched as market data and the latest reported figures frame the setup. The companys most recent numbers and the current trading context still matter more than headlines.

Extreme Makrofotografie von Pharmatablettten mit Tiefenschärfe und warmem Gegenlicht
IQVIA Holdings Branchenprodukt US46266C1053 als extreme Makrofotografie weißer Pharmatabletten mit warmem Gegenlicht und Bokeh, Illustration mit AI erstellt.

IQVIA Holdings (ISIN US46266C1053) stock is trading with investors focused on the latest reported figures and current market context. The most recent snapshot in this call does not add a fresh company-specific catalyst, so the numbers now do the talking.

Latest reported numbers

In the latest reported quarter available in this call, IQVIA posted revenue of USD 3.81 billion and adjusted diluted EPS of USD 2.37, while net income reached USD 190 million. That compares with revenue growth of 5.3 percent year over year, giving the report a clear quantified angle.

The same update also showed adjusted EBITDA of USD 824 million and a 21.6 percent adjusted EBITDA margin. For investors, that margin is the key detail because it shows how much of the top line turned into operating profit power.

Market level now

IQVIA stock had no verified price snapshot in the materials used for this article, so the market view has to lean on the companys reported metrics instead. The core comparison is still direct: USD 3.81 billion in revenue versus 5.3 percent growth and USD 824 million in adjusted EBITDA.

A second comparison matters as well. The adjusted EBITDA margin of 21.6 percent gives the quarter a cleaner read than revenue alone, and it places the operating profile in a more focused light for the next print.

Go deeper

More on IQVIA Holdings

The companys latest report and market context are the two numbers that currently shape the stock.

Products and revenue mix

IQVIAs business still rests on contract research, technology, and data services for life-science clients. That mix matters because the companys revenue base of USD 3.81 billion in the latest reported quarter depends on recurring project flow and client spending trends.

What matters next

IQVIA stock is the kind of name where a margin move can matter more than a headline. With adjusted EBITDA at USD 824 million and a 21.6 percent margin in the latest reported quarter, the next update will be judged on execution as much as on growth.

IQVIA Holdings snapshot

  • Company: IQVIA Holdings Inc.
  • ISIN: US46266C1053
  • Ticker: IQV
  • Trading venue: NYSE
  • Sector / Industry: Health Care / Life Sciences Tools & Services
  • Index membership: S&P 500

Disclaimer...

en | US46266C1053 | IQVIA HOLDINGS | boerse | 70044455 | bgmi